Literature DB >> 19142124

Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action.

Jochen Mutschler, Alexander Diehl, Falk Kiefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19142124     DOI： 10.1097/JCP.0b013e3181934451

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  10 in total

1.  Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens.

Authors:  Meriem Gaval-Cruz; Richard B Goertz; Daniel J Puttick; Dawn E Bowles; Rebecca C Meyer; Randy A Hall; Daijin Ko; Carlos A Paladini; David Weinshenker
Journal:  Addict Biol       Date:  2014-08-13       Impact factor: 4.280

2.  A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram.

Authors:  John D Roache; Roberta Kahn; Thomas F Newton; Christopher L Wallace; William L Murff; Richard De La Garza; Oscar Rivera; Ann Anderson; Jurij Mojsiak; Ahmed Elkashef
Journal:  Drug Alcohol Depend       Date:  2011-06-21       Impact factor: 4.492

3.  Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.

Authors:  Avanti Gokhale; Alysia Vrailas-Mortimer; Jennifer Larimore; Heather S Comstra; Stephanie A Zlatic; Erica Werner; Daniel F Manvich; P Michael Iuvone; David Weinshenker; Victor Faundez
Journal:  Hum Mol Genet       Date:  2015-07-21       Impact factor: 6.150

4.  Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.

Authors:  Richard De La Garza; Marcy J Bubar; Crystal L Carbone; F Gerard Moeller; Thomas F Newton; Noelle C Anastasio; Tod A Harper; David L Ware; Michael A Fuller; Gaylyn J Holstein; Jason B Jayroe; Stephen I Bandak; Kirsten Z Reiman; Ann C Neale; Lesley B Pickford; Kathryn A Cunningham
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-17       Impact factor: 5.067

5.  Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.

Authors:  Daniel F Manvich; Lauren M DePoy; David Weinshenker
Journal:  J Pharmacol Exp Ther       Date:  2013-09-25       Impact factor: 4.030

Review 6.  mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse.

Authors:  Meriem Gaval-Cruz; David Weinshenker
Journal:  Mol Interv       Date:  2009-08

7.  Can ropinirole modulate reinforcing subjective effects of cocaine in humans?

Authors:  Angelo Giovanni Icro Maremmani; Matteo Pacini; Luca Rovai; Fabio Rugani; Liliana Dell'osso; Icro Maremmani
Journal:  Front Psychiatry       Date:  2011-08-02       Impact factor: 4.157

8.  Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Roberto Frau; Gian L Gessa
Journal:  Brain Behav       Date:  2015-09-24       Impact factor: 2.708

9.  Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice.

Authors:  Meriem Gaval-Cruz; Larry Cameron Liles; Paul Michael Iuvone; David Weinshenker
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

Review 10.  Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse.

Authors:  Carlos Roncero; Alfonso C Abad; Antonio Padilla-Mata; Elena Ros-Cucurull; Carmen Barral; Miquel Casas; Lara Grau-López
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.